Entry Inhibitors in HIV Therapy

Entry Inhibitors in HIV Therapy-1

Edited by Jacqueline D. Reeves and Cynthia A. Derdeyn


The entry of HIV into cellular targets is mediated by the envelope protein (Env) which studs the viral surface. A major milestone for inhibition of HIV entry was achieved in 2003 with the approval of the HIV fusion inhibitor enfuvirtide.

Leave a Reply

Your email address will not be published. Required fields are marked *